Description
Kerendia (finerenone) is used to decrease the risk of worsening of kidney failure, kidney disease, cardiovascular death, heart attack, and heart failure hospitalization in adults who have chronic kidney disease and type 2 diabetes.
Fact Table |
Formula |
C21H22N4O3 |
License |
US DailyMed |
Bioavailability |
43.5% |
Legal status |
Rx-Only |
Chemical Name |
Finerenone |
Elimination half-life |
17.4 hours |
Dosage (Strength) |
10mg, 20mg |
Pregnancy |
Consult Doctor |
Brands |
Kerendia |
Protein binding |
92% |
PubChem CID |
60150535 |
MedlinePlus |
a621038 |
ChEBI |
- |
ATC code |
C03DA05 |
DrugBank |
DB16165 |
KEGG |
D10633 |
Routes of administration |
By mouth |
Directions
Kerendia is available in 10 mg and 20 mg oral tablets.
Follow the instructions that come with your Kerendia prescription. If you have any questions or concerns about your prescription, talk to your doctor or pharmacist.
Your starting dose will depend on your kidney function and potassium levels in your blood. The typical starting dosage is to take 10 mg or 20 mg by mouth once daily with or without food. After 4 weeks, your doctor may increase your dose to 20 mg once daily depending on your kidney function and blood potassium levels.
Ingredients
Finerenone, a nonsteroidal mineralocorticoid receptor antagonist, is the active ingredient contained in Kerendia.
Contraindications
Do not take Kerendia with other CYP3A4 inhibitors. Ask your doctor if you are unsure whether or not you are taking other CYP3A4 inhibitors.
Do not take Kerendia if you have a condition in which your adrenal glands do not make enough hormones.
Cautions
- Before you start treatment with Kerendia, it's important to discuss the following with your doctor:
- All the medications you take. These include prescription and over-the-counter medications, as well as vitamins and herbal supplements.
- Your allergies.
- Your health conditions, including liver problems.
- Your pregnancy status.
- Your breastfeeding status. Breastfeeding should be avoided during Kerendia treatment and for one day after treatment.
- Kerendia can cause elevated potassium levels in the blood. Seek emergency care right away if you experience muscle weakness, rapid heartbeats, trouble breathing, chest pain, nausea, or vomiting.
- Do not consume grapefruit or grapefruit juice during treatment with Kerendia.
Side Effects
The most common side effects of Kerendia include elevated potassium levels in the blood, low blood pressure, and low sodium levels in the blood; however, these are not all the possible side effects of Kerendia. Contact your doctor right away if you have side effects that concern you or won't go away.
References:
- Kerendia (finerenone) tablets, for oral use. Whippany, NJ: Bayer HealthCare Pharmaceuticals, Inc.; 2021.
- Kerendia (finerenone) tablets. Important Safety Information. Accessed March 25, 2022.
- Adrenal Insufficiency. Endocrine Society. January 23, 2022. Accessed March 25, 2022.
- What is Hyperkalemia? National Kidney Foundation. Accessed March 25, 2022.
About Dr. Savannah Muncy (Page Author)
Dr. Muncy (PharmD) studied science and education as an undergraduate before attending the Appalachian College of Pharmacy where she completed her PharmD in three years. She is currently using her pharmacy and healthcare expertise to write medical content for clients all around the world. She is focused on delivering the most current, accurate, and engaging information to healthcare professionals and patients. Read More....
IMPORTANT NOTE:
The above information is intended to increase awareness of health information and does not suggest treatment or diagnosis. This information is not a substitute for individual medical attention and should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. See your health care professional for medical advice and treatment.
Product Code : 13658